The clinical study of beta 3-agonist (Betanis) for lower urinary tract symptoms mainly for overactive bladder
Not Applicable
- Conditions
- lower urinary tract symptoms (overactive bladder)
- Registration Number
- JPRN-UMIN000008084
- Lead Sponsor
- Dept. of Urology, Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) those who have critical infectious disease or have uncontrollable complications (2) those who have active urothelial cancer or prostate cancer (3) those who have critical heart disease (4) those who have the episode of urinary retention (5) those who are considered as inappropriate for this study by the responsible doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety, efficiency
- Secondary Outcome Measures
Name Time Method I-PSS, OABSS